Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Georgia | Incontinence, prolapse & sacral neuromodulation · Florida | |
|---|---|---|
| Surgeons, 2024 | 34 | 107 |
| Medicare fee-for-service cases | 2,423 | 6,731 |
| Growth since 2019 (Medicare FFS) | −0.2%/yr | +0.7%/yr |
| Forecast cases (Medicare FFS) | 2,640 in 2030 | 7,480 in 2030 |
| Forecast growth | +1.4%/yr to 2030 | +1.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.8 | 3.0 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 14% (+1 pts since 2019) | 30% (+10 pts since 2019) |
| Cases per surgeon | 71 | 63 |
| Top 10 surgeons' share | 58% | 30% |
| Surgeons growing | 7 | 13 |
| New since the base year | 3 | 20 |
| Likely to stop billing it | 10 by 2026 | 25 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $9,825 | $12K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.